Canakinumab and cardiovascular outcomes: results of the CANTOS trial

Canakinumab and cardiovascular outcomes: results of the CANTOS trial

IL-1 cytokines are mainly responsible for controlling a series of pro-inflammatory reactions induced in response to pathogen mediated tissue injury. Among the IL-1 cytokine family, IL-1 β results in upregulation of genes responsible for boosting immune system reactivity and inflammatory response. Wi...

Full description

Bibliographic Details
Main Authors: Syed Raza Shah, Zainab Abbasi, Mazia Fatima, Rohan Kumar Ochani, Waqas Shahnawaz, Muhammad Asim Khan, Syed Arbab Shah
Format: Article
Language:English
Published: Greater Baltimore Medical Center 2018-01-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
CANTOS
Canakinumab
cardiovascular
mortality
antiinflammatory
Online Access:http://dx.doi.org/10.1080/20009666.2018.1428023

Internet

http://dx.doi.org/10.1080/20009666.2018.1428023

Similar Items